Immune Cells Are Differentially Affected by SARS-CoV-2 Viral Loads in K18-hACE2 Mice
Authors
Jung Ah Kim ; Sung-Hee Kim ; Jeong Jin Kim ; Hyuna Noh ; Su-Bin Lee ; Haengdueng Jeong ; Jiseon Kim ; Donghun Jeon ; Jung Seon Seo ; Dain On ; Suhyeon Yoon ; Sang Gyu Lee ; Youn Woo Lee ; Hui Jeong Jang ; In Ho Park ; Jooyeon Oh ; Sang-Hyuk Seok ; Yu Jin Lee ; Seung-Min Hong ; Se-Hee An ; Joon-Yong Bae ; Jung-Ah Choi ; Seo Yeon Kim ; Young Been Kim ; Ji-Yeon Hwang ; Hyo-Jung Lee ; Hong Bin Kim ; Dae Gwin Jeong ; Daesub Song ; Manki Song ; Man-Seong Park ; Kang-Seuk Choi ; Jun Won Park ; Jun-Won Yun ; Jeon-Soo Shin ; Ho-Young Lee ; Ho-Keun Kwon ; Jun-Young Seo ; Ki Taek Nam ; Heon Yung Gee ; Je Kyung Seong
Viral load and the duration of viral shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are important determinants of the transmission of coronavirus disease 2019. In this study, we examined the effects of viral doses on the lung and spleen of K18-hACE2 transgenic mice by temporal histological and transcriptional analyses. Approximately, 1×105 plaque-forming units (PFU) of SARS-CoV-2 induced strong host responses in the lungs from 2 days post inoculation (dpi) which did not recover until the mice died, whereas responses to the virus were obvious at 5 days, recovering to the basal state by 14 dpi at 1×102 PFU. Further, flow cytometry showed that number of CD8+ T cells continuously increased in 1×102 PFU-virus-infected lungs from 2 dpi, but not in 1×105 PFU-virus-infected lungs. In spleens, responses to the virus were prominent from 2 dpi, and number of B cells was significantly decreased at 1×105 PFU; however, 1×102 PFU of virus induced very weak responses from 2 dpi which recovered by 10 dpi. Although the defense responses returned to normal and the mice survived, lung histology showed evidence of fibrosis, suggesting sequelae of SARS-CoV-2 infection. Our findings indicate that specific effectors of the immune response in the lung and spleen were either increased or depleted in response to doses of SARS-CoV-2. This study demonstrated that the response of local and systemic immune effectors to a viral infection varies with viral dose, which either exacerbates the severity of the infection or accelerates its elimination.